Altis Biosystems
Kevin Causey is a seasoned professional with extensive experience in business development and leadership within the biotechnology and pharmaceutical industries. Currently serving as a Board Member at Altis Biosystems and CEO/Co-Founder of Predictive, LLC, Kevin has also held advisory roles at Humabiologics®, Inc. and Trialist. Previously, Kevin was the Chairman of the Board at ImmuONE and Vice President of Business Development at MatTek Corporation, among other notable positions. Kevin's educational background includes a Bachelor of Science in Biological Sciences from North Carolina State University and a Master of Business Administration from Pfeiffer University.
This person is not in the org chart
Altis Biosystems
Altis Biosystems is a spin-out company from the University of North Carolina at Chapel Hill and based in Durham, North Carolina. The intellectual property behind its stem cell platform was created as part of an NIH Transformative Research Award to develop a microfluidic organ-on-a-chip mimic of the human colon and awarded to Altis’ scientific founders.